3D Printing in Healthcare Market by Component (System, Materials, and Services), Technology [Droplet Deposition, Photopolymerization, Laser Beam Melting, Electronic Beam Melting (EBM), Laminated Object Manufacturing, and Others], Application (External Wearable Devices, Clinical Study Devices, Implants, and Tissue Engineering), and End User (Medical & Surgical Centers, Pharmaceutical & Biotechnology Companies, and Academic Institutions): Global Opportunity Analysis and Industry Forecast, 2021-2030
- ALL4676973
- 361 Pages
- September 2021
- Diagnostic and Biotech
The 3D printing technology has witnessed increased adoption in the healthcare sector. However, surge in requirement of variations in the technical aspects of the printers is expected to boost the market. In addition, the development of portable and energy-efficient 3D printers is a rapidly emerging trend in the 3D printing industry.
Furthermore, utilization of this technology to predict the mechanical and tensile strength, apart from offering flexibility to the 3D-printed objects, is projected to increase its applicability in novel healthcare applications. Product innovation and increase in applications of 3D printing in the healthcare sector are the major factors, which are expected to drive the market growth.
The market is expected to witness significant growth during the forecast period, owing to numerous technological innovations in this sector. In addition, heavy investments for R&D activities, rapid expansion of customer base, increase in scope of biomedical applications, and extensive R&D activities for the advancement in 3D printers at the academic and industrial level have fueled the market growth. Furthermore, collaborations between academic institutions, hospitals, and companies have supplemented the growth of the market. However, high costs of printers, lack of structured regulatory frameworks related to approvals for 3D printers, unfavorable reimbursement policies, copyright & patent infringement concerns, biocompatibility issues of 3D-printed medical devices, and lack of technical expertise are the major factors hampering the growth of the market. Conversely, untapped markets in the developing countries are expected to provide lucrative opportunities for the market players. The impact of the driving factors is expected to surpass that of the restraints.
This report provides comprehensive competitive analysis and profiles of prominent market players such as 3D Systems Corporation, Exone Company, Formlabs Inc., GE, Materialise NV, Oxferd Performance Materials, Inc., Organovo Holdings, Inc., Proto Labs, SLM Solutions Group AG, and Stratasys Ltd.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global 3D printing in healthcare market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the products and end users of 3D Printing in Healthcare used across the globe.
Key market players and their strategies have been analysed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Component
• System
• Materials
o Polymers
Photopolymers
Thermoplastics
o Metals & Alloys
o Ceramics
o Others
• Services
By Technology
• Droplet Deposition
o Fused Filament Fabrication (FFF) Technology
o Low-temperature Deposition Manufacturing (LDM)
o Multiphase Jet Solidification (MJS)
• Photopolymerization
o Stereolithography (SLA)
o Continuous Liquid Interface Production (CLIP)
o Two-photon Polymerization (2PP)
• Laser Beam Melting
o Selective Laser Sintering (SLS)
o Selective Laser Melting (SLM)
o Direct Metal Laser Sintering (DMLS)
• Electronic Beam Melting (EBM)
• Laminated Object Manufacturing
• Others
o Color Jet Printing
o MultiJet Printing
By Application
• External Wearable Devices
o Hearing Aids
o Prosthesis & Orthotics
o Dental Products
• Clinical Study Devices
o Drug Testing
o Anatomical Models
• Implants
o Surgical Guides
o Cranio-maxillofacial Implants
o Orthopedic Implants
• Tissue Engineering
By End User
• Medical & Surgical Centers
• Pharmaceutical & Biotechnology Companies
• Academic Institutions
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o Spain
o Italy
o UK
o Rest of Europe
• Asia-Pacific
o Australia
o Japan
o India
o China
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
KEY MARKET PLAYERS
• 3D Systems Corporation
• Exone Company
• Formlabs Inc.
• General Electric,
• Materialise NV
• Oxferd Performance Materials, Inc.
• Organovo Holdings, Inc.
• Proto Labs
• SLM Solutions Group AG
• Stratasys Ltd
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Conventional versus 3D printing technology
3.3.Latest developments in 3D printing in healthcare technology
3.4.Key findings
3.4.1.Top investment pockets
3.4.2.Top winning strategies
3.5.Ethical and legal concerns
3.6.Porter’s five force analysis
3.7.Value chain analysis
3.8.Patent analysis
3.8.1.By Region
3.8.2.By Year
3.8.3.By applicant
3.9.Market dynamics
3.9.1.Drivers
3.9.1.1.Technological advancements in 3D printing
3.9.1.2.Customization & personalization
3.9.1.3.Augmented R&D investments
3.9.1.4.Presence of large patient pool
3.9.1.5.Increase in biomedical applications
3.9.2.Restraints
3.9.2.1.High cost associated with 3D printing
3.9.2.2.Increase in reimbursement challenges
3.9.2.3.Upsurge in copyright &patent concerns
3.9.2.4.Lack of skilled labor
3.9.3.Opportunities
3.9.3.1.Rise in pharmaceutical applications
3.9.3.2.Availability of bioprinting tissues & organs
3.10.COVID-19 impact analysis on global 3D printing in healthcare market
CHAPTER 4:3D PRINTING IN HEALTH CARE MARKET, BY COMPONENT
4.1.Overview
4.1.1.Market size and forecast, by component
4.2.System
4.2.1.Key trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Materials
4.3.1.Key trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.4.1.Polymers
4.3.4.1.1.Market size and forecast
4.3.4.1.2.Photopolymers
4.3.4.1.3.Thermoplastics
4.3.4.2.Metals & alloys
4.3.4.2.1.Market size and forecast
4.3.4.3.Ceramics
4.3.4.3.1.Market size and forecast
4.3.4.4.Others
4.3.4.4.1.Market size and forecast
4.4.Services
4.4.1.Key trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY
5.1.Overview
5.1.1.Market size and forecast
5.2.Droplet deposition
5.2.1.Key trends and growth opportunities
5.2.2.Market size and forecast
5.2.3.Market analysis, by country
5.2.3.1.Fused filament fabrication (FFF) technology
5.2.3.2.Low-temperature deposition manufacturing (LDM)
5.2.3.3.Multiple jet solidification (MJS)
5.3.Photopolymerization
5.3.1.Key trends and growth opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.3.3.1.Stereolithography (SLA)
5.3.3.2.Continuous liquid interface production (CLIP)
5.3.3.3.Two-photon polymerization (2PP)
5.4.Laser beam melting
5.4.1.Key trends and growth opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country
5.4.3.1.Selective laser sintering (SLS)
5.4.3.2.Selective laser melting (SLM)
5.4.3.3.Direct metal laser sintering (DMLS)
5.5.Electron beam melting (EBM)
5.5.1.Key trends and growth opportunities
5.5.2.Market size and forecast
5.5.3.Market analysis, by country
5.6.Laminated object manufacturing (LOM)
5.6.1.Key trends and growth opportunities
5.6.2.Market size and forecast
5.6.3.Market analysis, by country
5.7.Others
5.7.1.Key trends and growth opportunities
5.7.2.Market size and forecast
5.7.3.Market analysis, by country
5.7.3.1.Color jet printing
5.7.3.2.MultiJet printing
CHAPTER 6:3D PRINTING IN HEALTH CARE MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.External wearable devices
6.2.1.Key trends and growth opportunities
6.2.2.Market size and forecast
6.2.3.Market analysis, by country
6.2.3.1.Hearing aids
6.2.3.2.Prosthesis & orthotics
6.2.3.3.Dental products
6.3.Clinical study devices
6.3.1.Key trends and growth opportunities
6.3.2.Market size and forecast
6.3.3.Market analysis, by country
6.3.3.1.Drug testing
6.3.3.2.Anatomical models
6.4.Implants
6.4.1.Key trends and growth opportunities
6.4.2.Market size and forecast
6.4.3.Market analysis, by country
6.4.3.1.Surgical guides
6.4.3.2.Cranio-maxillofacial implants
6.4.3.3.Orthopedic implants
6.5.Tissue engineering
6.5.1.Key trends and growth opportunities
6.5.2.Market size and forecast
6.5.3.Market analysis, by country
CHAPTER 7:3D PRINTING IN HEALTH CARE MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast, by end user
7.2.Medical & surgical centers
7.2.1.Key trends and growth opportunities
7.2.2.Market size and forecast
7.3.Pharma & biotech companies
7.3.1.Key trends and growth opportunities
7.3.2.Market size and forecast
7.4.Academic institutions
7.4.1.Key trends and growth opportunities
7.4.2.Market size and forecast
CHAPTER 8:3D PRINTING HEALTHCARE MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast, by component
8.2.North America
8.2.1.Key trends and growth opportunities
8.2.2.Market size and forecast, by component
8.2.3.Market size and forecast, by technology
8.2.4.Market size and forecast, by application
8.2.5.Market size and forecast, by end user
8.2.6.Market size and forecast, by country
8.2.6.1.U.S. market size and forecast, by component
8.2.6.2.U.S. market size and forecast, by technology
8.2.6.3.U.S. market size and forecast, by application
8.2.6.4.U.S. market size and forecast, by end user
8.2.6.5.Canada market size and forecast, by component
8.2.6.6.Canada market size and forecast, by technology
8.2.6.7.Canada market size and forecast, by application
8.2.6.8.Canada market size and forecast, by end user
8.2.6.9.Mexico market size and forecast, by component
8.2.6.10.Mexico market size and forecast, by technology
8.2.6.11.Mexico market size and forecast, by application
8.2.6.12.Mexico market size and forecast, by end user
8.3.Europe
8.3.1.Key trends and growth opportunities
8.3.2.Market size and forecast, by component
8.3.3.Market size and forecast, by technology
8.3.4.Market size and forecast, by application
8.3.5.Market size and forecast, by end user
8.3.6.Market size and forecast, by country
8.3.6.1.Germany market size and forecast, by component
8.3.6.2.Germany market size and forecast, by technology
8.3.6.3.Germany market size and forecast, by application
8.3.6.4.Germany market size and forecast, by end user
8.3.6.5.France market size and forecast, by component
8.3.6.6.France market size and forecast, by technology
8.3.6.7.France market size and forecast, by application
8.3.6.8.France market size and forecast, by end user
8.3.6.9.UK market size and forecast, by component
8.3.6.10.UK market size and forecast, by technology
8.3.6.11.UK market size and forecast, by application
8.3.6.12.UK market size and forecast, by end user
8.3.6.13.Italy market size and forecast, by component
8.3.6.14.Italy market size and forecast, by technology
8.3.6.15.Italy market size and forecast, by application
8.3.6.16.Italy market size and forecast, by end user
8.3.6.17.Spain market size and forecast, by component
8.3.6.18.Spain market size and forecast, by technology
8.3.6.19.Spain market size and forecast, by application
8.3.6.20.Spain market size and forecast, by end user
8.3.6.21.Rest of Europe market size and forecast, by component
8.3.6.22.Rest of Europe market size and forecast, by technology
8.3.6.23.Rest of Europe market size and forecast, by application
8.3.6.24.Rest of Europe market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key trends and growth opportunities
8.4.2.Market size and forecast, by component
8.4.3.Market size and forecast, by technology
8.4.4.Market size and forecast, by application
8.4.5.Market size and forecast, by end user
8.4.6.Market size and forecast, by country
8.4.6.1.Japan market size and forecast, by component
8.4.6.2.Japan market size and forecast, by technology
8.4.6.3.Japan market size and forecast, by application
8.4.6.4.Japan market size and forecast, by end user
8.4.6.5.China market size and forecast, by component
8.4.6.6.China market size and forecast, by technology
8.4.6.7.China market size and forecast, by application
8.4.6.8.China market size and forecast, by end user
8.4.6.9.India market size and forecast, by component
8.4.6.10.India market size and forecast, by technology
8.4.6.11.India market size and forecast, by application
8.4.6.12.India market size and forecast, by end user
8.4.6.13.Australia market size and forecast, by component
8.4.6.14.Australia market size and forecast, by technology
8.4.6.15.Australia market size and forecast, by application
8.4.6.16.Australia market size and forecast, by end user
8.4.6.17.Rest of Asia-Pacific market size and forecast, by component
8.4.6.18.Rest of Asia-Pacific market size and forecast, by technology
8.4.6.19.Rest of Asia-Pacific market size and forecast, by application
8.4.6.20.Rest of Asia-Pacific market size and forecast, by end user
8.5.LAMEA
8.5.1.Key trends and opportunities
8.5.2.Market size and forecast, by component
8.5.3.Market size and forecast, by technology
8.5.4.Market size and forecast, by application
8.5.5.Market size and forecast, by end user
8.5.6.Market size and forecast, by country
8.5.6.1.Brazil market size and forecast, by component
8.5.6.2.Brazil market size and forecast, by technology
8.5.6.3.Brazil market size and forecast, by application
8.5.6.4.Brazil market size and forecast, by end user
8.5.6.5.Saudi Arabia market size and forecast, by component
8.5.6.6.Saudi Arabia market size and forecast, by technology
8.5.6.7.Saudi Arabia market size and forecast, by application
8.5.6.8.Saudi Arabia market size and forecast, by end user
8.5.6.9.South Africa market size and forecast, by component
8.5.6.10.South Africa market size and forecast, by technology
8.5.6.11.South Africa market size and forecast, by application
8.5.6.12.South Africa market size and forecast, by end user
8.5.6.13.Rest of LAMEA market size and forecast, by component
8.5.6.14.Rest of LAMEA market size and forecast, by technology
8.5.6.15.Rest of LAMEA market size and forecast, by application
8.5.6.16.Rest of LAMEA market size and forecast, by end user
CHAPTER 9:COMPANY PROFILES
9.1.3D SYSTEMS CORPORATION
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.EXONE COMPANY
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.FORMLABS INC.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments
9.4.GENERAL ELECTRIC (GE ADDITIVE)
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.MATERIALISE NV
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments
9.6.ORGANOVO HOLDINGS, INC.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.OXFORD PERFORMANCE MATERIALS INC.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Key strategic moves and developments
9.8.PROTO LABS, INC.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.SLM SOLUTIONS GROUP AG
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.STRATASYS LTD
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments
TABLE 01.PATENT ANALYSIS, BY REGION (2017–2020)
TABLE 02.PATENT ANALYSIS, BY YEAR, (2017-2020)
TABLE 03.PATENT ANALYSIS, BY APPLICANT (2018–2020)
TABLE 04.3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 05.3D PRINTING IN HEALTHCARE MARKET FOR SYSTEMS, BY REGION, 2020–2030 ($MILLION)
TABLE 06.3D PRINTING IN HEALTHCARE MARKET FOR MATERIALS, BY REGION, 2020–2030 ($MILLION)
TABLE 07.3D PRINTING IN HEALTHCARE MARKET FOR MATERIALS, BY TYPE, 2020–2030 ($MILLION)
TABLE 08.3D PRINTING IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 09.3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 10.3D PRINTING IN HEALTHCARE MARKET FOR DROPLET DEPOSITION/FUSED DEPOSITION MODELING, BY REGION, 2020–2030 ($MILLION)
TABLE 11.3D PRINTING IN HEALTHCARE MARKET FOR PHOTOPOLYMERIZATION, BY REGION, 2020–2030 ($MILLION)
TABLE 12.3D PRINTING IN HEALTHCARE MARKET FOR LASER BEAM MELTING, BY REGION, 2020–2030 ($MILLION)
TABLE 13.3D PRINTING IN HEALTHCARE MARKET FOR ELECTRONIC BEAM MELTING, BY REGION, 2020–2030 ($MILLION)
TABLE 14.3D PRINTING IN HEALTHCARE MARKET FOR LAMINATED OBJECT MANUFACTURING, BY REGION, 2020–2030 ($MILLION)
TABLE 15.3D PRINTING IN HEALTHCARE MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 16.3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 17.3D PRINTING IN HEALTHCARE MARKET FOR EXTERNAL WEARABLE DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 18.3D PRINTING IN HEALTHCARE MARKET FOR CLINICAL STUDY DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 19.3D PRINTING IN HEALTHCARE MARKET FOR IMPLANTS, BY REGION, 2020–2030 ($MILLION)
TABLE 20.3D PRINTING IN HEALTHCARE MARKET FOR TISSUE ENGINEERING, BY REGION, 2020–2030 ($MILLION)
TABLE 21.3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 22.3D PRINTING IN HEALTHCARE MARKET FOR MEDICAL AND SURGICAL CENTRES, BY GEOGRAPHY, 2020–2030 ($MILLION)
TABLE 23.3D PRINTING IN HEALTHCARE MARKET FOR PHARMA & BIOTECH COMPANIES, BY GEOGRAPHY, 2020–2030 ($MILLION)
TABLE 24.3D PRINTING IN HEALTHCARE MARKET FOR ACADEMIC INSTITUTIONS, BY GEOGRAPHY, 2020–2030 ($MILLION)
TABLE 25.3D PRINTING IN HEALTHCARE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 27.NORTH AMERICA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 28.NORTH AMERICA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 29.NORTH AMERICA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 30.NORTH AMERICA 3D PRINTING IN HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31.U.S. 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 32.U.S. 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 33.U.S. 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 34.U.S. 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 35.CANADA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 36.CANADA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 37.CANADA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 38.CANADA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39.MEXICO 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 40.MEXICO 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 41.MEXICO 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 42.MEXICO 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 43.EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 44.EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 45.EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 46.EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 47.EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 48.GERMANY 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 49.GERMANY 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 50.GERMANY 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51.GERMANY 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 52.FRANCE 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 53.FRANCE 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 54.FRANCE 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 55.FRANCE 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 56.UK 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 57.UK 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 58.UK 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 59.UK 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 60.ITALY 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 61.ITALY 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 62.ITALY 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63.ITALY 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64.SPAIN 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 65.SPAIN 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 66.SPAIN 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67.SPAIN 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 68.REST OF EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 69.REST OF EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 70.REST OF EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 71.REST OF EUROPE 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 72.ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 73.ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 74.ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 75.ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76.ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 77.JAPAN 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 78.JAPAN 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 79.JAPAN 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 80.JAPAN 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 81.CHINA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 82.CHINA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 83.CHINA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 84.CHINA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 85.INDIA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 86.INDIA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 87.INDIA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 88.INDIA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 89.AUSTRALIA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 90.AUSTRALIA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 91.AUSTRALIA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 92.AUSTRALIA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 93.REST OF ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 94.REST OF ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 95.REST OF ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 96.REST OF ASIA-PACIFIC 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 97.LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 98.LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 99.LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 100.LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 101.LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 102.BRAZIL 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 103.BRAZIL 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 104.BRAZIL 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 105.BRAZIL 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 106.SAUDI ARABIA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 107.SAUDI ARABIA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 108.SAUDI ARABIA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 109.SAUDI ARABIA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 110.SOUTH AFRICA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 111.SOUTH AFRICA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 112.SOUTH AFRICA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 113.SOUTH AFRICA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 114.REST OF LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY COMPONENT, 2020–2030 ($MILLION)
TABLE 115.REST OF LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 116.REST OF LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 117.REST OF LAMEA 3D PRINTING IN HEALTHCARE MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 118.3D SYSTEMS: COMPANY SNAPSHOT
TABLE 119.3D SYSTEMS: PRODUCT PORTFOLIO
TABLE 120.EXONE COMPANY: COMPANY SNAPSHOT
TABLE 121.EXONE COMPANY: OPERATING SEGMENTS
TABLE 122.EXONE COMPANY: PRODUCT PORTFOLIO
TABLE 123.EXONE COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.FORMLABS: COMPANY SNAPSHOT
TABLE 125.FORMLABS: PRODUCT PORTFOLIO
TABLE 126.GE: COMPANY SNAPSHOT
TABLE 127.GE: OPERATING SEGMENTS
TABLE 128.GE ADDITIVE: PRODUCT PORTFOLIO
TABLE 129.MATERIALISE: COMPANY SNAPSHOT
TABLE 130.MATERIALISE: OPERATING SEGMENTS
TABLE 131.MATERIALISE: PRODUCT PORTFOLIO
TABLE 132.ORGANOVO HOLDINGS: COMPANY SNAPSHOT
TABLE 133.ORGANOVO HOLDINGS: PRODUCT PORTFOLIO
TABLE 134.ORGANOVO HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135.OPM: COMPANY SNAPSHOT
TABLE 136.OPM: PRODUCT PORTFOLIO
TABLE 137.PROTOLABS: COMPANY SNAPSHOT
TABLE 138.PROTOLABS: OPERATING SEGMENTS
TABLE 139.PROTOLABS: PRODUCT PORTFOLIO
TABLE 140.SLM SOLUTIONS: COMPANY SNAPSHOT
TABLE 141.SLM SOLUTIONS: OPERATING SEGMENTS
TABLE 142.SLM SOLUTIONS: PRODUCT PORTFOLIO
TABLE 143.SLM SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 144.STRATASYS: COMPANY SNAPSHOT
TABLE 145.STRATASYS: PRODUCT PORTFOLIO
TABLE 146.STRATASYS: KEY STRATEGIC MOVES AND DEVELOPMENTS
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
